Clinicopathologic considerations: How can we fine tune our approach to sarcoma?

Seminars in Oncology

Volumn 38, Issue SUPPL. 3, 2011, Pages

  Demicco, Elizabeth G ^a   Lazar, Alexander J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD99 ANTIGEN; CYTOKERATIN; DESMIN; PROTEIN S 100;

ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; CYTOGENETICS; GENE AMPLIFICATION; GENE MUTATION; HUMAN; KARYOTYPING; MOLECULAR PATHOLOGY; NOMOGRAM; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; SARCOMA; SOFT TISSUE SARCOMA;

COMBINED MODALITY THERAPY; HUMANS; INTERDISCIPLINARY COMMUNICATION; NEOPLASM GRADING; NEOPLASM STAGING; SARCOMA; SIGNAL TRANSDUCTION; SOFT TISSUE NEOPLASMS;

EID: 80355142264     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2011.09.001     Document Type: Article

References (104)

1. M.A. Clark, C. Fisher, I. Judson, and J.M. Thomas Soft-tissue sarcomas in adults N Engl J Med 353 2005 701 711 (Pubitemid 41175678)
2. G.D. Demetri, S. Antonia, and R.S. Benjamin National Comprehensive Cancer Network Soft Tissue Sarcoma Panel Soft tissue sarcoma J Natl Compr Canc Netw 8 2010 630 674
3. A. Jemal, R.C. Tiwari, and T. Murray Cancer statistics, 2004 CA Cancer J Clin 54 2004 8 29 (Pubitemid 38443417)
4. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics CA Cancer J Clin 60 2010 277 300
5. V.T. DeVita Jr, S. Hellman, and S.A. Rosenberg Cancer: principles and practice of oncology 6th ed. 2001 Lippincott Williams & Wilkens Philadelphia, PA 1841 1891
6. S. Steen, and G. Stephenson Current treatment of soft tissue sarcoma Proc Bayl Univ Med Cent 21 2008 392 396
7. E.A. Nedea, and T.F. DeLaney Sarcoma and skin radiation oncology Hematol Oncol Clin North Am 20 2006 401 429 (Pubitemid 44226308)
8. J.M. Coindre, P. Terrier, and L. Guillou Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group Cancer 91 2001 1914 1926 (Pubitemid 32424119)
9. H.D. Dorfman, B. Czerniak, R. Kotz, D. Vanel, Y.K. Park, and K.K. Unni WHO classification of tumours of bone: introduction C.D.M. Fletcher, K.K. Unni, F. Mertens, World Health Organization classification of tumours Pathology and genetics of tumours of soft tissue and bone 2002 IARC Press Lyon, France 225 232
10. F. Bertoni, P. Bacchini, and P.C.W. Hogendoorn Chondrosarcoma C.D.M. Fletcher, K.K. Unni, F. Mertens, World Health Organization classification of tumors Pathology and genetics of tumours of soft tissue and bone 2002 IARC Press Lyon, France 242 251
11. A.H. Beck, R.B. West, and M. van de Rijn Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers Virchows Arch 456 2010 141 151
12. J.M. Coindre Immunohistochemistry in the diagnosis of soft tissue tumours Histopathology 43 2003 1 16 (Pubitemid 36836582)
13. C. Fisher Immunohistochemistry in diagnosis of soft tissue tumours Histopathology 58 2010 1001 1012
14. J.F. Graadt van Roggen, J.V. Bovee, J. Morreau, and P.C. Hogendoorn Diagnostic and prognostic implications of the unfolding molecular biology of bone and soft tissue tumours J Clin Pathol 52 1999 481 489 (Pubitemid 29309203)
15. C.D.M. Fletcher, A. Rydholm, S. Singer, M. Sundaram, and J.M. Coindre Soft tissue tumours: Epidemiology, clinical features, histopathological typing and grading C.D.M. Fletcher, K.K. Unni, F. Mertens, World Health Organization classification of tumours Pathology and genetics of tumours of soft tissue and bone 2002 IARC Press Lyon, France 9 18
16. P.C. Hogendoorn, F. Collin, and S. Daugaard Changing concepts in the pathological basis of soft tissue and bone sarcoma treatment Eur J Cancer 40 2004 1644 1654 (Pubitemid 38902898)
17. L.G. Kindblom, H.E. Remotti, F. Aldenborg, and J.M. Meis-Kindblom Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal Am J Pathol 152 1998 1259 1269 (Pubitemid 28221878)
18. M. Miettinen, M. Virolainen, and M. Sarlomo-Rikala Gastrointestinal stromal tumorsvalue of CD34 antigen in their identification and separation from true leiomyomas and schwannomas Am J Surg Pathol 19 1995 207 216
19. F. Mitelman, B. Johansson, and F. Mertens The impact of translocations and gene fusions on cancer causation Nat Rev Cancer 7 2007 233 245 (Pubitemid 46480968)
20. F. Mertens, I. Panagopoulos, and N. Mandahl Genomic characteristics of soft tissue sarcomas Virchows Arch 456 2010 129 139
21. A.M. Oliveira, A.R. Perez-Atayde, and C.Y. Inwards USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts Am J Pathol 165 2004 1773 1780 (Pubitemid 39435174)
22. F. Mertens, C.R. Antonescu, and P. Hohenberger Translocation-related sarcomas Semin Oncol 36 2009 312 323
23. C. Errani, L. Zhang, and Y.S. Sung A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites Genes Chromosomes Cancer 50 2011 644 653
24. C.R. Antonescu, L. Zhang, and N.E. Chang EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene Genes Chromosomes Cancer 49 2010 1114 1124
25. K.H. Hallor, R. Sciot, and J. Staaf Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions J Pathol 217 2009 716 727
26. C.R. Antonescu, L. Zhang, G.P. Nielsen, A.E. Rosenberg, P.D. Cin, and C.D. Fletcher Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor Genes Chromosomes Cancer 50 2011 757 764
27. L. Wang, T. Motoi, and R. Khanin Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data Mod Pathol 24 S1 2011 abstract 82
28. M.R. Erickson-Johnson, M.M. Chou, and B.R. Evers Fusion of non-muscle myosin MYH9 to the USP6 oncogene in nodular fasciitis Mod Pathol 24 S1 2011 abstract 39
29. S. Mejia-Guerrero, M. Quejada, and N. Gokgoz Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma Genes Chromosomes Cancer 49 2010 518 525
30. B. Rekhi, A.L. Folpe, and M. Deshmukh Jambhekar NA (2011) Sclerosing epithelioid fibrosarcomaa report of two cases with cytogenetic analysis of FUS gene rearrangement by FISH technique Pathol Oncol Res 17 2011 145 148
31. E. Möller, N. Mandahl, F. Mertens, and I. Panagopoulos Molecular identification of COL6A3-CSF1 fusion transcripts in tenosynovial giant cell tumors Genes Chromosomes Cancer 47 2008 21 25 (Pubitemid 350191460)
32. S. Jain, R. Xu, V.G. Prieto, and P. Lee Molecular classification of soft tissue sarcomas and its clinical applications Int J Clin Exp Pathol 3 2010 416 428
33. N. Riggi, L. Cironi, M.L. Suva, and I. Stamenkovic Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET J Pathol 213 2007 4 20 (Pubitemid 47354561)
34. S. Romeo, and A.P. Dei Tos Soft tissue tumors associated with EWSR1 translocation Virchows Arch 456 2010 219 234
35. J.V. Bovee, and P.C. Hogendoorn Molecular pathology of sarcomas: concepts and clinical implications Virchows Arch 456 2010 193 199
36. D. Mahalingam, A. Mita, and K. Sankhala Targeting sarcomas: novel biological agents and future perspectives Curr Drug Targets 10 2009 937 949
37. A. Lazar, L.V. Abruzzo, R.E. Pollock, S. Lee, and B. Czerniak Molecular diagnosis of sarcomas: Chromosomal translocations in sarcomas Arch Pathol Lab Med 130 2006 1199 1207 (Pubitemid 44168792)
38. J.A. van Doorninck, L. Ji, and B. Schaub Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group J Clin Oncol 28 2010 1989 1994
39. S. Avigad, I.J. Cohen, and J. Zilberstein The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors Cancer 100 2004 105318
40. C. Fisher Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations Virchows Arch 456 2010 153 166
41. P. Rutkowski, A. Wozniak, and T. Switaj Advances in molecular characterization and targeted therapy in dermatofibrosarcoma protuberans Sarcoma 2011;Mar 30 [Epub ahead of print]
42. C.M. Coffin, A. Patel, S. Perkins, K.S. Elenitoba-Jackson, E. Perlman, and C.A. Griffin ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor Mod Pathol 14 2001 569 576 (Pubitemid 32554081)
43. C.A. Griffen, A.L. Hawkins, C. Dvorak, C. Henkle, T. Ellingham, and E.J. Perlman Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors Cancer Res 59 1999 2776 2780 (Pubitemid 29283106)
44. J.E. Butrynski, D.R. D'Adamo, and J.L. Hornick Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor N Engl J Med 363 2010 1727 1733
45. J.S. Wunder, K. Eppert, S.R. Burrow, N. Gokgoz, R.S. Bell, and I.L. Andrulis Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas Oncogene 18 1999 783 788 (Pubitemid 29080336)
46. B.P. Rubin, C.D. Blanke, G.D. Demetri Cancer Committee, College of American Pathologists Protocol for the examination of specimens from patients with gastrointestinal stromal tumor Arch Pathol Lab Med 134 2010 165 170
47. A.J. Lazar, D. Tuvin, and S. Hajibashi Specific mutations in the β-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors Am J Pathol 173 2008 1518 1527
48. E.M. Jackson, A.J. Sievert, and X. Gai Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors Clin Cancer Res 15 2009 1923 1930
49. J.A. Biegel, L. Tan, F. Zhang, L. Wainwright, P. Russo, and L.B. Rorke Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors Clin Cancer Res 8 2002 3461 3467 (Pubitemid 35340722)
50. P. Modena, E. Lualdi, and F. Facchinetti SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas Cancer Res 65 2005 4012 4019 (Pubitemid 40775637)
51. K. Kohashi, T. Izumi, and Y. Oda Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor Hum Pathol 40 2009 349 355
52. J.L. Hornick, P. Dal Cin, and C.D. Fletcher Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma Am J Surg Pathol 33 2009 542 550
53. L. Guillou, and A. Aurias Soft tissue sarcomas with complex genomic profiles Virchows Arch 456 2010 201 217
54. E. de Alava Molecular pathology in sarcomas Clin Transl Oncol 9 2007 130 144
55. L.C. Strong, W.R. Williams, and M.A. Tainsky The Li-Fraumeni syndrome: from clinical epidemiology to molecular genetics Am J Epidemiol 135 1992 190 199
56. R.S. Herbst, S.G. Eckhardt, and R. Kurzrock Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer J Clin Oncol 28 2010 2839 2846
57. H.U. Kontny, K. Hmmerle, R. Klein, P. Shayan, C.L. Mackall, and C.M. Niemeyer Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis Cell Death Differ 8 2001 506 514 (Pubitemid 32492771)
58. N. Mitsiades, V. Poulaki, C. Mitsiades, and M. Tsokos Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5 Cancer Res 61 2001 2704 2712 (Pubitemid 32685858)
59. I. Petak, L. Douglas, D.M. Tillman, R. Vernes, and J.A. Houghton Pediatric rhabdomyosarcoma cell lines are resistant to Fas-induced apoptosis and highly sensitive to TRAIL-induced apoptosis Clin Cancer Res 6 2000 4119 4127
60. S. Tomek, W. Koestler, and P. Horak Trail-induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell lines Eur J Cancer 39 2003 1318 1329 (Pubitemid 36579206)
61. S. Bouralexis, M. Clayer, and G.J. Atkins Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicin Int J Oncol 24 2004 1263 1270
62. S. Wang, W. Ren, and J. Liu TRAIL and doxorubicin combination induces proapoptotic and antiangiogenic effects in soft tissue sarcoma in vivo Clin Cancer Res 16 2010 2591 2604
63. G. Picarda, F. Lamoureux, and L. Geffroy Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival Clin Cancer Res 16 2010 2363 2374
64. B. Rikhof, S. de Jong, A.J. Suurmeijer, C. Meijer, and W.T. van der Graaf The insulin-like growth factor system and sarcomas J Pathol 217 2009 469 482
65. M.C. Heinrich, C.L. Corless, and G.D. Demetri Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor J Clin Oncol 21 2003 4342 4349 (Pubitemid 46621810)
66. C. Tarn, L. Rink, and E. Merkel Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors Proc Natl Acad Sci U S A 105 2008 8387 8392 (Pubitemid 351904765)
67. S. Vemulapalli, A. Mita, Y. Alvarado, K. Sankhala, and M. Mita The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomas Target Oncol 6 2011 29 39
68. J. Barretina, B.S. Taylor, and S. Banerji Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy Nat Genet 42 2010 715 721
69. Demicco EG, Torres KE, Ghadimi MP, et al. Involvement of the PI3K/Akt pathway in myxoid/round cell liposarcoma. Mod Pathol. In press.
70. Y. Dobashi, S. Suzuki, E. Sato, Y. Hamada, T. Yanagawa, and A. Ooi EGFR-dependent and independent activation of Akt/mTOR cascade in bone and soft tissue tumors Mod Pathol 22 2009 1328 1340
71. A. Potti, A.K. Ganti, and K. Tendulkar Determination of vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas and the role of overexpression in leiomyosarcoma J Cancer Res Clin Oncol 130 2004 52 56 (Pubitemid 38161248)
72. C.C. West, N.J. Brown, D.C. Mangham, R.J. Grimer, and M.W. Reed Microvessel density does not predict outcome in high grade soft tissue sarcoma Eur J Surg Oncol 31 2005 1198 1205 (Pubitemid 41819208)
73. S. Sleijfer, E. Van de Graaft, and J. Blay Angiogenesis inhibition in non-GIST soft tissue sarcomas Oncologist 13 2008 1193 1200
74. L.H. Baker, E.K. Rowinsky, and D. Mendelson Randomized, phase II study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced soft tissue sarcoma J Clin Oncol 26 2008 5583 5588
75. T. Mentzel, L.F. Brown, and H.F. Dvorak The association between tumour progression and vascularity in myxofibrosarcoma and myxoid/round cell liposarcoma Virchows Arch 438 2001 13 22 (Pubitemid 32128185)
76. P. Rutkowski, M. Debiec-Rychter, and Z. Nowecki Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection J Eur Acad Dermatol Venereol 25 2011 264 270
77. J.M. Coindre Grading of soft tissue sarcomas: review and update Arch Pathol Lab Med 130 2006 1448 1453
78. M. Trojani, G. Contesso, and J.M. Coindre Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system Int J Cancer 33 1984 37 42 (Pubitemid 14223231)
79. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, and A. Trotti AJCC cancer staging handbook 7th ed. 2010 Springer New York, NY
80. B.P. Rubin, K. Cooper, C.D. Fletcher Members of the Cancer Committee, College of American Pathologists Protocol for the examination of specimens from patients with tumors of soft tissue Arch Pathol Lab Med 134 2010 e31 e39
81. F.M. Brown, and C.D. Fletcher Problems in grading soft tissue sarcomas Am J Clin Pathol 114 Suppl 2000 82 89
82. L. Guillou, J. Coindre, and F. Bonichon Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma J Clin Oncol 15 1997 350 362 (Pubitemid 27020593)
83. G. Lahat, D. Tuvin, and C. Wei New perspectives for staging and prognosis in soft tissue sarcoma Ann Surg Oncol 15 2008 2739 2748
84. H. Nathan, C.P. Raut, and K. Thornton Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system Ann Surg 250 2009 970 976
85. D.A. Anaya, G. Lahat, and X. Wang Establishing prognosis in retroperitoneal sarcoma: a new histology-based paradigm Ann Surg Oncol 16 2009 667 675
86. W.F. Enneking, S.S. Spanier, and M.A. Goodman A system for the surgical staging of musculoskeletal sarcoma Clin Orthop Relat Res 153 1980 106 120 (Pubitemid 11217753)
87. M.W. Kattan, D.H. Leung, and M.F. Brennan Postoperative nomogram for 12-year sarcoma-specific death J Clin Oncol 20 2002 791 796 (Pubitemid 34111387)
88. F.C. Eilber, M.F. Brennan, F.R. Eilber, S.M. Dry, S. Singer, and M.W. Kattan Validation of the postoperative nomogram for 12-year sarcoma-specific mortality Cancer 101 2004 2270 2275 (Pubitemid 39458683)
89. L. Mariani, R. Miceli, and M.W. Kattan Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system Cancer 103 2005 402 408 (Pubitemid 40129301)
90. D.A. Anaya, G. Lahat, and X. Wang Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent Ann Oncol 21 2010 397 402
91. I. Ardoino, R. Miceli, and M. Berselli Histology-specific nomogram for primary retroperitoneal soft tissue sarcoma Cancer 116 2010 2429 2436
92. K.M. Dalal, M.W. Kattan, C.R. Antonescu, M.F. Brennan, and S. Singer Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk Ann Surg 244 2006 381 391
93. R.J. Canter, L.X. Qin, R.G. Maki, M.F. Brennan, M. Ladanyi, and S. Singer A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients Clin Cancer Res 14 2008 8191 8197
94. M.S. Kim, S.Y. Lee, and T.R. Lee Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma Ann Oncol 20 2009 955 960
95. J.S. Gold, M. Gönen, and A. Gutierrez Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: A retrospective analysis Lancet Oncol 10 2009 1045 1052
96. F. Chibon, P. Lagarde, and S. Salas Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity Nat Med 16 2010 781 787
97. E. Davicioni, D.H. Wai, and M.J. Anderson Diagnostic and prognostic sarcoma signatures Mol Diagn Ther 12 2008 359 374 (Pubitemid 352790450)
98. C.C. Lau Molecular classification of osteosarcoma Cancer Treat Res 152 2009 459 465
99. J.S. Biermann, D.R. Adkins, and R.S. Benjamin Bone cancer J Natl Compr Canc Netw 8 2010 688 712
100. V. Bramwell, J. Rouesse, and W. Steward Adjuvant CYVADIC chemotherapy for adult soft tissue sarcomareduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group J Clin Oncol 12 1994 1137 1149
101. W.G. Kraybill, J. Harris, and I.J. Spiro Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group trial 9514 J Clin Oncol 24 2006 619 625 (Pubitemid 46630425)
102. E. Gortzak, A. Azzarelli, and J. Buesa A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma Eur J Cancer 37 2001 1096 1103
103. R. Chugh, and L.H. Baker Pharmacotherapy of sarcoma Expert Opin Pharmacother 10 2009 1953 1963
104. T.F. DeLaney, I.J. Spiro, and H.D. Suit Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas Int J Radiat Oncol Biol Phys 56 2003 1117 1127 (Pubitemid 36794046)